New Strategies for the Treatment of Phenylketonuria (PKU)
AbstractPhenylketonuria (PKU) was the first inherited metabolic disease in which dietary treatment was found to prevent the disease’s clinical features. Treatment of phenylketonuria remains difficult due to progressive decrease in adherence to diet and the presence of neurocognitive defects despite therapy. This review aims to summarize the current literature on new treatment strategies. Additions to treatment include new, more palatable foods based on glycomacropeptide that contains very limited amount of aromatic amino acids, the administration of large neutral amino acids to prevent phenylalanine entry into the brain or tetrahydropterina cofactor capable of increasing residual activity of phenylalanine hydroxylase. Moreover, human trials have recently been performed with subcutaneous administration of phenylalanine ammonia-lyase, and further efforts are underway to develop an oral therapy containing phenylanine ammonia-lyase. Gene therapy also seems to be a promising approach in the near future. View Full-Text
Share & Cite This Article
Strisciuglio, P.; Concolino, D. New Strategies for the Treatment of Phenylketonuria (PKU). Metabolites 2014, 4, 1007-1017.
Strisciuglio P, Concolino D. New Strategies for the Treatment of Phenylketonuria (PKU). Metabolites. 2014; 4(4):1007-1017.Chicago/Turabian Style
Strisciuglio, Pietro; Concolino, Daniela. 2014. "New Strategies for the Treatment of Phenylketonuria (PKU)." Metabolites 4, no. 4: 1007-1017.